drugset / Trial / NCT03018301

Intravenous Ketamine and Postoperative Pain Following Cesarean Section.

NCT03018301

Phase 2 Unknown 80 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the analgesic effect of low-dose intravenous ketamine in pregnant mothers undergoing cesarean section under Bupivacaine spinal anesthesia.

Timeline

Start
2017-01
Primary completion
2017-06
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.25 mg/kg Intravenous

Indications

No indication recorded.